To validate differential expression of TRIP13, in important GI cancers (COAD, ESCA, GBM, LIHC, PAAD, and STAD), box plot analysis was performed, where we have noticed that PAAD and LIHC were only cancer conditions, that showed remarkably higher TRIP13 expression. This evidence concerns the gene TRIP13 and cancer.